Ritonavir-Induced Lipoatrophy and Dyslipidaemia Is Reversed by the Anti-Inflammatory Drug Leflunomide in a PPAR-γ-dependent Manner
Antiviral Therapy - United Kingdom
doi 10.3851/imp2039
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2012
Authors
Publisher
International Medical Press